Vitiligo and associated autoimmune disease: Retrospective review of 300 patients

Journal of Cutaneous Medicine and Surgery

Volumn 16, Issue 4, 2012, Pages 261-266

  Sawicki, Jakub ^a   Siddha, Sanjay ^a   Rosen, Cheryl ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CYANOCOBALAMIN; HEMOGLOBIN; THYROTROPIN;

ADOLESCENT; ADULT; AGED; ALOPECIA AREATA; ARTICLE; AUTOIMMUNE DISEASE; CANADA; CHILD; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE ASSOCIATION; FAMILY; FAMILY HISTORY; FEMALE; FISHER EXACT TEST; HALO NEVUS; HOSPITAL ADMISSION; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; ONSET AGE; PERNICIOUS ANEMIA; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS; VITILIGO;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, PERNICIOUS; AUTOIMMUNE DISEASES; CHILD; FEMALE; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; ONTARIO; PHOTOTHERAPY; PREVALENCE; RETROSPECTIVE STUDIES; VITILIGO;

EID: 84864119597     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1177/120347541201600408     Document Type: Article

References (32)

1. Kemp E, Waterman EA, Hawes BE, et al. The melanin concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo. J Clin Invest 2002;109:923-30. (Pubitemid 34275113)
2. Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997;84:223-43, doi:10.1006/clin.1997.4412. (Pubitemid 27398022)
3. Kemp EH, Waterman EA, Weetman AP. Autoimmune aspects of vitiligo. Autoimmunity 2001;34:65-77, doi:10.3109/08916930108994127. (Pubitemid 32888276)
4. Boissy RE, Manga P. On the etiology of contact/occupational vitiligo. Pigment Cell Res 2004;17:208-14, doi:10.1111/j.1600-0749.2004.00130.x. (Pubitemid 38724550)
5. Yu HS. Melanocyte destruction and repigmentation in vitiligo: a model for nerve cell damage and regrowth. J Biomed Sci 2002;9(6 Pt 2):564-73, doi:10.1007/BF02254984.
6. Nath SK, Majumder PP, Nordlund JJ. Genetic epidemiology of vitiligo: multilocus recessivity cross-validated. Am J Hum Genet 1994;55:981-90.
7. Gauthier Y, Cario-Andre M, Taieb A. A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res 2003;16:322-32, doi:10.1034/j.1600-0749.2003.00070.x. (Pubitemid 36950564)
8. Cario-André M, Pain C, Gauthier Y, Taieb A. The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis. Pigment Cell Res 2007;20:385-93. (Pubitemid 47390111)
9. Silva de Castro CC, do Nascimento LM, Walker G, et al. Genetic variants of the DDR1 gene are associated with vitiligo in two independent Brazilian population samples. J Invest Dermatol 2010;130:1813-8, doi:10.1038/jid.2010.34.
10. Passi S, Grandinetti M, Maggio F, et al. Epidermal oxidative stress in vitiligo. Pigment Cell Res 1998;11:81-5, doi:10.1111/j.1600-0749.1998.tb00714.x. (Pubitemid 128532953)
11. Liu L, Li C, Gao J, et al. Promoter variant in the catalase gene is associated with vitiligo in Chinese people. J Invest Dermatol 2010;130:2647-53, doi:10.1038/jid.2010.192.
12. Westerhof W, d'Ischia M. Vitiligo puzzle: the pieces fall in place. Pigment Cell Res 2007;20:345-59. (Pubitemid 47390114)
13. Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 1993;14:426-9, doi:10.1016/0167-5699(93) 90244-F.
14. Ochi Y, DeGroot LJ. Vitiligo in Graves' disease. Ann Intern Med 1969;71:935-40.
15. Dawber RPR. Integumentary associations of pernicious anemia. Br J Dermatol 1969;82:221-2, doi:10.1111/j.1365-2133.1970.tb12428.x.
16. Macaron C, Winter RA, Traisman HS, et al. Vitiligo and juvenile diabetes mellitus. Arch Dermatol 1977;113:1515-7, doi:10.1001/archderm.1977. 01640110035002. (Pubitemid 8232734)
17. Sharma VK, Dawn G, Kumar B. Profile of alopecia areata in Northern India. Int J Dermatol 1996;35:22-7, doi:10.1111/j.1365-4362.1996.tb01610.x. (Pubitemid 26034119)
18. Dunlop D. Eighty-six cases of Addison's disease. Br Med J 1963;2:887-91, doi:10.1136/bmj.2.5362.887.
19. Mihailova D, Grigorova R, Vassileva B, et al. Autoimmune thyroid disease in juvenile chronic arthritis and systemic lupus erythematosus. Adv Exp Med Biol 1999;455:55-60, doi:10.1007/978-1-4615-4857-7-8. (Pubitemid 32187441)
20. Alkhateeb A, Fain PR, Thody A, et al. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 2003;16:208-14, doi:10.1034/j.1600-0749.2003.00032.x. (Pubitemid 36597056)
21. Liu JB, Li M, Yang S, et al. Clinical profiles of vitiligo in China: an analysis of 3742 patients. Clin Exp Dermatol 2005;30:327-31, doi:10.1111/j.1365-2230.2005.01813.x. (Pubitemid 40835320)
22. Neufeld M, Maclaren NK, Blizzard RM. Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine 1981;60:355-62, doi:10.1097/00005792-198109000-00003. (Pubitemid 12247574)
23. Colton T. Statistics in medicine. Boston: Little Brown; 1974.
24. Zhang Z, Xu SX, Zhang FY, et al. The analysis of genetics and associated autoimmune diseases in Chinese vitiligo patients. Arch Dermatol Res 2009;301:167-73, doi:10.1007/s00403-008-0900-z.
25. Majumder PP, Nordlund JJ, Nath SK. Pattern of familial aggregation of vitiligo. Arch Dermatol 1993;129:994-8, doi:10.1001/archderm.1993. 01680290066010. (Pubitemid 23238604)
26. Handa S, Dogra S. Epidemiology of childhood vitiligo: a study of 625 patients from north India. Pediatr Dermatol 2003;20:207-10, doi:10.1046/j.1525- 1470.2003.20304.x. (Pubitemid 36736777)
27. Onunu AN, Kubeyinje EP. Vitiligo in the Nigerian African: a study of 351 patients in Benin City, Nigeria. Int J Dermatol 2003;42:800-2, doi:10.1046/j.1365-4362.2003.01908.x. (Pubitemid 37304044)
28. Ingordo V, Gentile C, Iannazzone S, et al. Vitiligo and autoimmunity: an epidemiological study in a representative sample of young Italian males. J Eur Acad Dermatol Venereol 2011;25:105-9, doi:10.1111/j.1468-3083.2010.03696.x.
29. Dave S, D'Souza M, Thappa DM, et al. High frequency of thyroid dysfunction in Indian patients with vitiligo. Indian J Dermatol 2003;48:68-72.
30. Gawkrodger DJ, Ormerod AD, Shaw L, et al. Guideline for the diagnosis and management of vitiligo. Br J Dermatol 2008;159:1051-76, doi:10.1111/j.1365- 2133.2008.08881.x.
31. Aoki Y, Belin RM, Clickner R, et al. Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). Thyroid 2007;17:1211-23, doi:10.1089/thy.2006.0235.
32. Herd RM, Hunter JA. Familial halo naevi. Clin Exp Dermatol 1998;23:68-9, doi:10.1046/j.1365-2230.1998.00327.x. (Pubitemid 28308367)